BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19773548)

  • 1. Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization.
    Clayton CC; Xu M; Chavkin C
    J Biol Chem; 2009 Nov; 284(46):31872-81. PubMed ID: 19773548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
    Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
    J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
    Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
    J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
    Bruchas MR; Macey TA; Lowe JD; Chavkin C
    J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization.
    McLaughlin JP; Xu M; Mackie K; Chavkin C
    J Biol Chem; 2003 Sep; 278(36):34631-40. PubMed ID: 12815037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of K(ir)3.1 in spinal cord is induced by acute inflammation, chronic neuropathic pain, and behavioral stress.
    Ippolito DL; Xu M; Bruchas MR; Wickman K; Chavkin C
    J Biol Chem; 2005 Dec; 280(50):41683-93. PubMed ID: 16223722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling events initiated by kappa opioid receptor activation: quantification and immunocolocalization using phospho-selective KOR, p38 MAPK, and K(IR) 3.1 antibodies.
    Lemos JC; Roth CA; Chavkin C
    Methods Mol Biol; 2011; 717():197-219. PubMed ID: 21370032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.
    Bruchas MR; Land BB; Aita M; Xu M; Barot SK; Li S; Chavkin C
    J Neurosci; 2007 Oct; 27(43):11614-23. PubMed ID: 17959804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
    Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
    J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin.
    Appleyard SM; Celver J; Pineda V; Kovoor A; Wayman GA; Chavkin C
    J Biol Chem; 1999 Aug; 274(34):23802-7. PubMed ID: 10446141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism.
    Lemos JC; Roth CA; Messinger DI; Gill HK; Phillips PE; Chavkin C
    J Neurosci; 2012 Sep; 32(36):12325-36. PubMed ID: 22956823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.
    Schattauer SS; Bedini A; Summers F; Reilly-Treat A; Andrews MM; Land BB; Chavkin C
    J Biol Chem; 2019 Nov; 294(45):16884-16896. PubMed ID: 31575661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand directed signaling differences between rodent and human κ-opioid receptors.
    Schattauer SS; Miyatake M; Shankar H; Zietz C; Levin JR; Liu-Chen LY; Gurevich VV; Rieder MJ; Chavkin C
    J Biol Chem; 2012 Dec; 287(50):41595-607. PubMed ID: 23086943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance.
    McLaughlin JP; Myers LC; Zarek PE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Chavkin C
    J Biol Chem; 2004 Jan; 279(3):1810-8. PubMed ID: 14597630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
    Schattauer SS; Kuhar JR; Song A; Chavkin C
    Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation of the kappa -opioid receptor regulates agonist efficacy.
    Appleyard SM; McLaughlin JP; Chavkin C
    J Biol Chem; 2000 Dec; 275(49):38281-5. PubMed ID: 10995763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
    Zan GY; Wang Q; Wang YJ; Chen JC; Wu X; Yang CH; Chai JR; Li M; Liu Y; Hu XW; Shu XH; Liu JG
    Neuroscience; 2016 Apr; 320():122-8. PubMed ID: 26826330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
    Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y
    Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2.
    Bruchas MR; Xu M; Chavkin C
    Neuroreport; 2008 Sep; 19(14):1417-22. PubMed ID: 18766023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.